Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis.

Trends Pharmacol Sci

KU Leuven, Laboratory of Molecular Cell Biology, Kasteelpark Arenberg 31, Leuven-Heverlee, Belgium. Electronic address:

Published: January 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tips.2022.10.004DOI Listing

Publication Analysis

Top Keywords

oteseconazole vivoja
4
vivoja prevention
4
prevention recurrent
4
recurrent vulvovaginal
4
vulvovaginal candidiasis
4
oteseconazole
1
prevention
1
recurrent
1
vulvovaginal
1
candidiasis
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!